CLINICAL_TRIALS trial_result · 2022-12-07

Clinical Trial Update: Phase 3 Study of OTO-104 in Subjects With Unilateral Meniere's Disease [Phase 3]

Phase 3 study of OTO-104 in unilateral Meniere's disease completed; results posted in 2022.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Otonomy, Inc. | Conditions: Meniere Disease | Phase 3 | Status: COMPLETED | Results posted: 2022-12-07